PortalPublikationenSystemische Psoriasistherapie während der Schwangerschaft. I...

Systemische Psoriasistherapie während der Schwangerschaft. Individuelle Beratung von schwangeren Patientinnen

Standard

Systemische Psoriasistherapie während der Schwangerschaft. Individuelle Beratung von schwangeren Patientinnen. / Stephan, B; Radtke, M A; Augustin, M.

in: HAUTARZT, Jahrgang 70, Nr. 12, 12.2019, S. 969-974.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Stephan, B, Radtke, MA & Augustin, M 2019, 'Systemische Psoriasistherapie während der Schwangerschaft. Individuelle Beratung von schwangeren Patientinnen', HAUTARZT, Jg. 70, Nr. 12, S. 969-974. https://doi.org/10.1007/s00105-019-4444-2

APA

Stephan, B., Radtke, M. A., & Augustin, M. (2019). Systemische Psoriasistherapie während der Schwangerschaft. Individuelle Beratung von schwangeren Patientinnen. HAUTARZT, 70(12), 969-974. https://doi.org/10.1007/s00105-019-4444-2

Vancouver

Stephan B, Radtke MA, Augustin M. Systemische Psoriasistherapie während der Schwangerschaft. Individuelle Beratung von schwangeren Patientinnen. HAUTARZT. 2019 Dez;70(12):969-974. https://doi.org/10.1007/s00105-019-4444-2

Bibtex

@article{daa94123eadc44c9b6b42bdeb3fd55b0,
title = "Systemische Psoriasistherapie w{\"a}hrend der Schwangerschaft. Individuelle Beratung von schwangeren Patientinnen",
abstract = "Systemic therapy of pregnant patients with psoriasis requires special attention and has to be adapted to disease activity throughout the pregnancy. With the approval of the first tumor necrosis factor alpha inhibitors for the treatment of these patients, a new range of options has to be discussed with the women. If the inflammatory presentation of the psoriasis demands systemic therapy, the decision for treatment should be made as early as possible, preferably before the onset of pregnancy.",
keywords = "Female, Humans, Immunologic Factors/therapeutic use, Pregnancy, Pregnancy Complications/drug therapy, Psoriasis/drug therapy, Referral and Consultation, Tumor Necrosis Factor-alpha/antagonists & inhibitors",
author = "B Stephan and Radtke, {M A} and M Augustin",
year = "2019",
month = dec,
doi = "10.1007/s00105-019-4444-2",
language = "Deutsch",
volume = "70",
pages = "969--974",
journal = "HAUTARZT",
issn = "0017-8470",
publisher = "Springer",
number = "12",

}

RIS

TY - JOUR

T1 - Systemische Psoriasistherapie während der Schwangerschaft. Individuelle Beratung von schwangeren Patientinnen

AU - Stephan, B

AU - Radtke, M A

AU - Augustin, M

PY - 2019/12

Y1 - 2019/12

N2 - Systemic therapy of pregnant patients with psoriasis requires special attention and has to be adapted to disease activity throughout the pregnancy. With the approval of the first tumor necrosis factor alpha inhibitors for the treatment of these patients, a new range of options has to be discussed with the women. If the inflammatory presentation of the psoriasis demands systemic therapy, the decision for treatment should be made as early as possible, preferably before the onset of pregnancy.

AB - Systemic therapy of pregnant patients with psoriasis requires special attention and has to be adapted to disease activity throughout the pregnancy. With the approval of the first tumor necrosis factor alpha inhibitors for the treatment of these patients, a new range of options has to be discussed with the women. If the inflammatory presentation of the psoriasis demands systemic therapy, the decision for treatment should be made as early as possible, preferably before the onset of pregnancy.

KW - Female

KW - Humans

KW - Immunologic Factors/therapeutic use

KW - Pregnancy

KW - Pregnancy Complications/drug therapy

KW - Psoriasis/drug therapy

KW - Referral and Consultation

KW - Tumor Necrosis Factor-alpha/antagonists & inhibitors

U2 - 10.1007/s00105-019-4444-2

DO - 10.1007/s00105-019-4444-2

M3 - SCORING: Zeitschriftenaufsatz

C2 - 31218417

VL - 70

SP - 969

EP - 974

JO - HAUTARZT

JF - HAUTARZT

SN - 0017-8470

IS - 12

ER -